BackSabra Healthcare REIT Overview

Sabra Healthcare REIT Total Current Liabilities

Sabra Healthcare REIT's total current liabilities is $1.3B.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$1.26B
28.66% YoYΔ $-504.70M vs prior year quarter

Peer average

Loading

Sabra Healthcare REIT Total Current Liabilities History

Loading

Sabra Healthcare REIT vs. peers: Total Current Liabilities Comparison

Loading

Sabra Healthcare REIT Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Sabra Healthcare REIT (SBRA) FAQ

Sabra Healthcare REIT's total current liabilities stands at $1.3B as of March 2026. That compares with $1.8B in the prior-year period — down 28.7% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Sabra Healthcare REIT reported $1.3B in total current liabilities versus $1.8B a year earlier — a 28.7% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $1.8B in the prior-year period — down 28.7% year over year. Sustained growth in total current liabilities can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Sabra Healthcare REIT's total current liabilities evolved across reporting periods, while the comparison chart places SBRA next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Finance, total current liabilities is commonly used to spot outliers. Sabra Healthcare REIT's reading of $1.3B is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.